224 related articles for article (PubMed ID: 22160056)
1. Many multiple myelomas: making more of the molecular mayhem.
Chesi M; Bergsagel PL
Hematology Am Soc Hematol Educ Program; 2011; 2011():344-53. PubMed ID: 22160056
[TBL] [Abstract][Full Text] [Related]
2. Molecular Pathogenesis of Multiple Myeloma: Clinical Implications.
Maura F; Bergsagel PL
Hematol Oncol Clin North Am; 2024 Apr; 38(2):267-279. PubMed ID: 38199896
[TBL] [Abstract][Full Text] [Related]
3. Early genetic events provide the basis for a clinical classification of multiple myeloma.
Kuehl WM; Bergsagel PL
Hematology Am Soc Hematol Educ Program; 2005; ():346-52. PubMed ID: 16304402
[TBL] [Abstract][Full Text] [Related]
4. Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma.
Bergsagel PL; Kuehl WM
Immunol Rev; 2003 Aug; 194():96-104. PubMed ID: 12846810
[TBL] [Abstract][Full Text] [Related]
5. Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma.
Chesi M; Kuehl WM; Bergsagel PL
Ann Oncol; 2000; 11 Suppl 1():131-5. PubMed ID: 10707795
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathogenesis and a consequent classification of multiple myeloma.
Bergsagel PL; Kuehl WM
J Clin Oncol; 2005 Sep; 23(26):6333-8. PubMed ID: 16155016
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma.
Shaughnessy J; Gabrea A; Qi Y; Brents L; Zhan F; Tian E; Sawyer J; Barlogie B; Bergsagel PL; Kuehl M
Blood; 2001 Jul; 98(1):217-23. PubMed ID: 11418483
[TBL] [Abstract][Full Text] [Related]
8. The molecular classification of multiple myeloma.
Zhan F; Huang Y; Colla S; Stewart JP; Hanamura I; Gupta S; Epstein J; Yaccoby S; Sawyer J; Burington B; Anaissie E; Hollmig K; Pineda-Roman M; Tricot G; van Rhee F; Walker R; Zangari M; Crowley J; Barlogie B; Shaughnessy JD
Blood; 2006 Sep; 108(6):2020-8. PubMed ID: 16728703
[TBL] [Abstract][Full Text] [Related]
9. MMSET: role and therapeutic opportunities in multiple myeloma.
Xie Z; Chng WJ
Biomed Res Int; 2014; 2014():636514. PubMed ID: 25093175
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing primary and secondary translocations in multiple myeloma.
Gabrea A; Leif Bergsagel P; Michael Kuehl W
DNA Repair (Amst); 2006 Sep; 5(9-10):1225-33. PubMed ID: 16829212
[TBL] [Abstract][Full Text] [Related]
11. Advances in biology and therapy of multiple myeloma.
Barillé-Nion S; Barlogie B; Bataille R; Bergsagel PL; Epstein J; Fenton RG; Jacobson J; Kuehl WM; Shaughnessy J; Tricot G
Hematology Am Soc Hematol Educ Program; 2003; ():248-78. PubMed ID: 14633785
[TBL] [Abstract][Full Text] [Related]
12. The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts.
Chesi M; Nardini E; Lim RS; Smith KD; Kuehl WM; Bergsagel PL
Blood; 1998 Nov; 92(9):3025-34. PubMed ID: 9787135
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal translocations t(4;14), t(11;14) and proliferation rate stratify patients with mature plasma cell myelomas into groups with different survival probabilities: a molecular epidemiologic study on tissue microarrays.
Tinguely M; Jenni B; Reineke T; Korol D; Kofler A; Rousson V; Dommann-Scherrer C; Maurer R; Moch H; Probst-Hensch NM
Am J Surg Pathol; 2007 May; 31(5):690-6. PubMed ID: 17460451
[TBL] [Abstract][Full Text] [Related]
14. Advances in biology of multiple myeloma: clinical applications.
Hideshima T; Bergsagel PL; Kuehl WM; Anderson KC
Blood; 2004 Aug; 104(3):607-18. PubMed ID: 15090448
[TBL] [Abstract][Full Text] [Related]
15. V. Molecular classification and risk stratification of myeloma.
Bergsagel PL; Chesi M
Hematol Oncol; 2013 Jun; 31 Suppl 1(0 1):38-41. PubMed ID: 23775647
[No Abstract] [Full Text] [Related]
16. Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients.
Keats JJ; Maxwell CA; Taylor BJ; Hendzel MJ; Chesi M; Bergsagel PL; Larratt LM; Mant MJ; Reiman T; Belch AR; Pilarski LM
Blood; 2005 May; 105(10):4060-9. PubMed ID: 15677557
[TBL] [Abstract][Full Text] [Related]
17. Evidence of a role for the novel zinc-finger transcription factor ZKSCAN3 in modulating Cyclin D2 expression in multiple myeloma.
Yang L; Wang H; Kornblau SM; Graber DA; Zhang N; Matthews JA; Wang M; Weber DM; Thomas SK; Shah JJ; Zhang L; Lu G; Zhao M; Muddasani R; Yoo SY; Baggerly KA; Orlowski RZ
Oncogene; 2011 Mar; 30(11):1329-40. PubMed ID: 21057542
[TBL] [Abstract][Full Text] [Related]
18. Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses.
Fabris S; Agnelli L; Mattioli M; Baldini L; Ronchetti D; Morabito F; Verdelli D; Nobili L; Intini D; Callea V; Stelitano C; Lombardi L; Neri A
Genes Chromosomes Cancer; 2005 Feb; 42(2):117-27. PubMed ID: 15543617
[TBL] [Abstract][Full Text] [Related]
19. The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity.
Lauring J; Abukhdeir AM; Konishi H; Garay JP; Gustin JP; Wang Q; Arceci RJ; Matsui W; Park BH
Blood; 2008 Jan; 111(2):856-64. PubMed ID: 17942756
[TBL] [Abstract][Full Text] [Related]
20. Chromosome translocations in multiple myeloma.
Bergsagel PL; Kuehl WM
Oncogene; 2001 Sep; 20(40):5611-22. PubMed ID: 11607813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]